tiprankstipranks

Exact Sciences price target raised to $96 from $81 at Benchmark

Benchmark analyst Bruce Jackson raised the firm’s price target on Exact Sciences to $96 from $81 and keeps a Buy rating on the shares. Exact Sciences’s investor day event was preceded by the release of positive clinical data for the company’s Cologuard 2.0, which demonstrated notable improvement in the false positive rate vs. the original test, the analyst tells investors in a research note.

Confident Investing Starts Here:

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on EXAS:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue